11Evidence A

Walking 7,000–8,000 steps per day, or accumulating 150–300 minutes of brisk walking each week

People who walk roughly 7,800 steps daily have a mortality risk roughly 45% lower than those walking only 3,500 steps. The same pattern holds when measured by time: those who engage in 150–300 minutes of brisk walking weekly face about 30% lower risk than inactive individuals. Beyond a certain threshold, further increases bring little extra benefit; for people aged 60 and older, 6,000–8,000 steps per day is sufficient. Meeting either the step-count or duration target is enough.

Cost

It costs nothing. In terms of steps, walking 60–90 minutes…

Benefit

Combining 15 cohort studies, which only recorded data without randomly assigning participants, a total of 47,4…

Cost

It costs nothing. In terms of steps, walking 60–90 minutes daily can easily be split into short bouts during commutes or errands. In terms of time, it requires just 20–45 minutes per day. The real challenge is maintaining this habit over the long term.

Benefit

Combining 15 cohort studies, which only recorded data without randomly assigning participants, a total of 47,471 people and 3,013 deaths were observed. Dividing people into four tiers based on daily step counts, the median for the lowest tier was 3,553 steps/day. The medians for the other three tiers were 5,801, 7,842, and 10,901 steps/day. The mortality risk for these three tiers was approximately 40%, 45%, and 53% lower than the lowest tier, respectively (HR 0.60, 0.55, 0.47). For people over 60, the benefits plateaued after walking 6,000–8,000 steps; for those under 60, the plateau occurred after 8,000–10,000 steps. Another analysis pooling multiple studies showed effectiveness starting from approximately 3,867 steps/day. After that, for every additional 1,000 steps/day, the mortality risk decreased by about 15%. Regarding exercise duration: pooling multiple cohort studies (recording only, without randomly assigning participants), those exercising at 1–2 times the lower limit of the guidelines had a mortality risk approximately 31% lower than those who do not exercise (HR 0.69). This amount corresponds to 7.5–15 MET·h/week, roughly equivalent to 150–300 minutes/week of brisk walking. Those who did not reach the lower limit also had a risk approximately 20% lower (HR 0.80). Those reaching 3–5 times the lower limit had a risk approximately 39% lower (HR 0.61), which is the peak of the reduction. Increasing beyond this does not result in a lower risk, but it also causes no harm (above 10 times is HR 0.69). Another pooled study using accelerometers: the top quartile with the most moderate-to-high intensity activity had a mortality risk approximately 48% lower than the bottom quartile (HR 0.52). An accelerometer is a wearable instrument for measuring actual physical activity. This pool included 8 studies, 36,383 people, with an average age of 62.6, and a median follow-up of only 5.8 years. The paper authors recalculated after excluding those who died within the first two years; the results remained basically unchanged, but they also noted that bias caused by "moving less because of illness" might still persist.

Original sources

Paluch AE 等 (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. Lancet Public Health. https://doi.org/10.1016/S2468-2667(21)00302-9;Banach M 等 (2023). The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwad229;Arem H 等 (2015). Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.0533;Ekelund U 等 (2019). Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. https://doi.org/10.1136/bmj.l4570

Open source link
Book note

Step counts and exercise duration refer to the same thing, just using a different metric; reaching either standard is sufficient. The segment from increasing from 4,000 to 7,000 steps is the most cost-effective; there is no need to force yourself to reach 10,000 steps. It should be noted that these types of studies are merely longitudinal records: the group that walks and moves the least includes those who were already ill and unable to walk. They move less because they are near death, not because they die early due to lack of movement. Therefore, the calculated differences are often overestimated. The studies using instruments to measure actual activity levels had shorter follow-up times and older participants. Therefore, the statement "hazard ratio 0.52, about 48% lower risk" may be an overstatement, which is an inference made in this book. However, the trend that more movement is better is clear.

My note